about
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenaden...
Read More
26.82
0.10
(0.37%)
400.0K
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Cg Oncology Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..